CLASS II Device recall · Reported 8 May 2019 · FDA Enforcement Report

cobas e 801 immunoassay analyzer recalled by Roche Diagnostics

Roche Diagnostics is recalling cobas e 801 immunoassay analyzer, distributed in 26 states. The recall was initiated on 15 Mar 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAll units may experience this issue.
Quantity recalled149

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1249-2019
FDA event ID
82394
Recalling firm
Roche Diagnostics, Indianapolis, IN
Classification
Class II
Status
Terminated
Recall initiated
15 Mar 2019
FDA classified
2 May 2019
Reported
8 May 2019
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Lead & Heavy Metals

Timeline

15 Mar 2019Recall initiated by company
2 May 2019Classified by FDA+48 days
8 May 2019Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The firm has confirmed complaints regarding signal drops on the cobas e 801 module after a ProCell II M bottle changeover, which may lead to incorrect medical decisions with respect to diagnostics and patient treatment.

Lead and other heavy metals accumulate in the body. Children are most at risk; even low levels can affect development.

Product as listed by the FDA

cobas e 801 immunoassay analyzer

Where it was distributed

Distributed to accounts in AL AZ CA CT FL HI IA IL IN KY LA MA MD ME MI MN MO NC NH NJ NY OH OR PA PR SC TN TX VA WA WI

AlabamaArizonaCaliforniaConnecticutFloridaIowaIllinoisKentuckyLouisianaMassachusettsMarylandMichiganMinnesotaMissouriNorth CarolinaNew HampshireNew JerseyNew YorkPennsylvaniaPuerto Rico

Questions about this recall

Is cobas e 801 immunoassay analyzer recalled?

Yes. Roche Diagnostics recalled cobas e 801 immunoassay analyzer on 15 Mar 2019. The recall is Class II and its status is Terminated. Recall number Z-1249-2019.

Why was it recalled?

The firm has confirmed complaints regarding signal drops on the cobas e 801 module after a ProCell II M bottle changeover, which may lead to incorrect medical decisions with respect to diagnostics and patient treatment.

Which lots are affected?

All units may experience this issue.

Where was it sold?

Distributed to accounts in AL AZ CA CT FL HI IA IL IN KY LA MA MD ME MI MN MO NC NH NJ NY OH OR PA PR SC TN TX VA WA WI

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Roche Diagnostics

All 39

Other Test Kits & Diagnostics recalls

All 2,656